FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutical industry, namely a wound healing gel. A wound healing gel for external application containing chitosan, salicylic acid, a biological regulator recovered from a bovine blood serum and represented an acidic protein fraction within the range of pH<3.0 and water taken in specific relation.
EFFECT: gel shows manifested wound healing activity.
2 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
ANTI-BURN GEL | 2011 |
|
RU2481121C2 |
COSMETIC COMPOSITION THAT PROMOTES ACTIVATION OF RESTORATIVE AND REGENERATIVE PROCESSES IN VARIOUS TYPES OF SKIN AND ITS DERIVATIVES, HAIR AND NAILS | 2023 |
|
RU2807113C1 |
PHARMACEUTICAL COMPOSITION POSSESSING THERAPEUTIC ACTION ON VARIOUS SKIN PATHOLOGIES | 2014 |
|
RU2549475C1 |
DERMAL OINTMENT | 2007 |
|
RU2362568C1 |
METHOD FOR OBTAINING A WOUND HEALING GEL CONTAINING TRYPSIN FOR EXTERNAL USE | 2021 |
|
RU2778511C1 |
PHARMACEUTICAL COMPOSITION HAVING THERAPEUTIC EFFECT IN VARIOUS SKIN PATHOLOGIES | 2019 |
|
RU2694059C1 |
METHOD FOR PREPARING GEL FOR WOUND AND BURN HEALING | 2013 |
|
RU2545893C1 |
PROTEIN-PEPTIDE COMPLEX HAVING A PROTECTIVE ACTION ON THE STATE OF TISSUES OF THE POSTERIOR EYE - SCLERAL SHELL, RETINA, PIGMENT EPITHELIUM, CHOROID | 2018 |
|
RU2701566C1 |
WOUND HEALING OINTMENT FOR THE TREATMENT OF THERMAL BURNS | 2022 |
|
RU2787377C1 |
PROTEIN-PEPTIDE COMPLEX INCREASING THE VIABILITY OF FOLLICULES IN MAMMAL OVARIANS | 2017 |
|
RU2660587C1 |
Authors
Dates
2012-12-10—Published
2011-04-15—Filed